In a preclinical study, a new CAR T-cell strategy was very successful against small cell lung cancer.

Published Date: 26 Apr 2023

In a preclinical study, a novel method of CAR T-cell therapy against small cell lung cancer (SCLC) has shown great promise. Our knowledge of CAR T has been expanded by the findings.

Read Full News

Latest News

Saline Lavage Shows No Clinical Benefit in Pleural Infection

Saline lavage, alone or combined with intrapleural enzyme therapy, confers no clinically meaningful advantage over intrapleural enzyme therapy alone in patients with pleural infection.

Your Patient Doesn’t Like Your Accent or Color: Now What?

Many doctors facing racism from patients stay silent, doubting they’ll be heard. Experts share strategies for handling bias when institutions fall short.

Does Cannabis Really Help PTSD? New Data Cast Doubt

Quitting cannabis may yield greater improvements in PTSD symptoms than continued use in adults with both PTSD and cannabis use disorder, a small study suggests.

Women At Risk as Taliban Curbs Hit Afghan Healthcare

Restrictions imposed by the Taliban are jeopardising the lives of women and their children who are sometimes denied emergency treatment, a ⁠U.N. human rights expert said.

Sterile Wolbachia-Infected Mosquitoes Reduce Dengue Risk

Releasing sterile Wolbachia-infected male Aedes aegypti mosquitoes substantially reduces the risk for dengue.

Australia’s Medicare Reforms Face Rural Stress Test

A parliamentary committee has launched an inquiry into the rural impacts of changes aimed at strengthening Medicare access and funding. Experts offer mixed reviews.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Latest News

Saline lavage, alone or combined with intrapleural enzyme therapy, confers no clinically meaningful advantage over intrapleural enzyme therapy alone in patients with pleural infection.

Many doctors facing racism from patients stay silent, doubting they’ll be heard. Experts share strategies for handling bias when institutions fall short.

Quitting cannabis may yield greater improvements in PTSD symptoms than continued use in adults with both PTSD and cannabis use disorder, a small study suggests.

Restrictions imposed by the Taliban are jeopardising the lives of women and their children who are sometimes denied emergency treatment, a ⁠U.N. human rights expert said.

Releasing sterile Wolbachia-infected male Aedes aegypti mosquitoes substantially reduces the risk for dengue.

A parliamentary committee has launched an inquiry into the rural impacts of changes aimed at strengthening Medicare access and funding. Experts offer mixed reviews.

News All Time

ACP Urges Concern for Health Policy Issues, with Shari Erickson, MPH Shari Erickson, MPH

Erickson discussed key health policy issues the ACP is pushing back against during the organization’s Internal Medicine meeting.

Reviving exhausted immune cells boosts tumor elimination

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body's immunity.

Precision therapy could stop breast cancer at the source

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of ...

What are the big unanswered questions about cancer? Experts discuss

Over the 40-year history of the University of Colorado Cancer Center, its investigators have answered many questions about cancer—what causes it, how to prevent it, and how to treat it. Those discoveries have helped many ...

Shaping immunity: The secrets behind the shape of neutrophils

Researchers at the Kennedy Institute have provided the most comprehensive overview to date of how the distinctive segmented nucleus of neutrophils influences their function in health and disease.

Surgery after immunotherapy boosts survival for liver cancer patients

A new Cedars-Sinai Cancer study shows that patients with advanced liver cancer who receive immunotherapy to shrink their tumors have improved outcomes after liver transplant or tumor removal.

Combination immunotherapy for rare cancers shows improved efficacy and survival rates

New results from a multicenter clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly improves treatment response in patients with advanced and difficult-to-treat cancers. The trial ...

Icotrokinra beneficial for adults, teens with plaque psoriasis

For adults and adolescents with moderate-to-severe plaque psoriasis, selective blockade of the interleukin-23 receptor with the targeted oral peptide icotrokinra yields a significantly higher incidence of skin clearance at ...

How controlling sunburn-triggered inflammation may prevent skin cancer

Sunlight is vital for human health as it helps the body produce essential nutrients, such as vitamin D. However, too much sun exposure can significantly increase the risk of skin cancer.

Cellular protein FGD3 boosts breast cancer chemotherapy and immunotherapy, study finds

A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a ...

Gut bacterium may sabotage liver cancer immunotherapy, study suggests

A research team led by the Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has identified a critical factor contributing ...

Researchers try bold new approach in a race to better treat autoimmune diseases

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other devastating autoimmune diseases—by reprogramming patients' out-of-whack immune systems.

Common cold virus may unlock better COVID vaccine

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill ...

Immune reactions found behind human rejection of transplanted pig kidneys

Researchers have uncovered and then overcome an obstacle that has led to the failure of pioneering efforts in xenotransplantation, in which an animal kidney is transplanted into a human.

Global reviews call for urgent action on endometriosis in most world regions

Two reviews published in The Lancet Obstetrics, Gynecology & Women's Health reveal stark global inequities in how endometriosis is recognized, treated, and prioritized in national health systems.

Mental and physical coaching before surgery prepares immune system and reduces complications, trial finds

The weeks leading up to a major surgery can be a time of uncertainty and worry for patients, many of whom anticipate the need for rehabilitation to get back on their feet. But if patients improve their physical and mental ...

Recommended News For You

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

Oleanolic acid from grapes may increase chemotherapy effectiveness

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information

Recommended Articles For You

The Importance of Iron Rich Foods in Preventing and Treating Anemia  

Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology 

Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL 

Introduction to Immune Thrombocytopenic Purpura 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer

2.

Acupuncture may alleviate nocturia in men treated for prostate cancer

3.

Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans

4.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

5.

Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

1.

Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer

2.

Unlocking The Power Of Cangrelor To Treat Heart Disease

3.

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review

4.

Uncovering the Role of Pap Smear in Oncology: A New Frontier in Cancer Detection

5.

Unveiling the Secrets of Early Cancer: Emerging Strategies to Decipher Its Biology

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

3.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

Navigating the Complexities of Ph Negative ALL - Part VII

5.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot